Boston Interactome, Inc.
Biotechnology company · Allston, Massachusetts, United States
Boston Interactome, Inc. is a biotechnology company headquartered in Allston, Massachusetts, United States. Its earliest recorded incorporation is in 2025. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $398,137 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2026.
Boston Interactome at a glance
What does Boston Interactome do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $398,137 in total (2025). NIH funding came from the National Institute on Drug Abuse, National Institute of General Medical Sciences.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2026).
Frequently asked questions about Boston Interactome
Where is Boston Interactome headquartered?
Boston Interactome, Inc. is headquartered in Allston, Massachusetts, United States.
What does Boston Interactome do?
Boston Interactome, Inc. is a biotechnology company.
When was Boston Interactome founded?
The earliest incorporation on record for Boston Interactome, Inc. is in 2025, according to public company registers.
Similar companies
- Concerto Biosciences, Inc.Allston, Massachusetts, United States
- Aperture Bio, Inc.Allston, Massachusetts, United States
- Absco Therapeutics, Inc.Allston, Massachusetts, United States
- PionEar Technologies, Inc.Allston, Massachusetts, United States
- Rowan Scientific CorpAllston, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences